MassHEAL - Reducing overdose deaths by 40% (2019-2023)
MassHEAL%20-%20减少%20过量%20死亡%20by%2040%%20(2019-2023)
基本信息
- 批准号:10891912
- 负责人:
- 金额:$ 79.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAcuteAddressAdoptionAgeAttentionAwarenessBlack PopulationsCOVID-19 pandemicCollaborationsCommunitiesComparison armContinuity of Patient CareDataData AnalysesData SourcesDeath RateDecision MakingDisparityEquityEthnic OriginEvidence based practiceFrequenciesGenderGoalsGrantHealthHealth Services AccessibilityHomelessnessIndividualInfrastructureInfusion proceduresInterventionKentuckyLearningLegal systemManuscriptsMassachusettsMeasuresMethodsMinority GroupsNaloxoneNational Institute of Drug AbuseNatureNew YorkNot Hispanic or LatinoOhioOutcomeOutcome StudyOverdose reductionParentsPersonsPharmaceutical PreparationsPoliciesPopulationPrevention educationPrevention strategyProcessProtocols documentationPublicationsRaceRandomizedReach, Effectiveness, Adoption, Implementation, and MaintenanceReportingResearch PersonnelResourcesSiteSpecial PopulationSurveysTimeTrainingUnderserved PopulationUnited States Substance Abuse and Mental Health Services AdministrationWaiting ListsWorkarmblack mencomparison interventioncontextual factorsdemographicsdesigndisparity reductionethnic disparityethnic minorityethnic minority populationhealinghealth equityimplementation strategyinsightmedication for opioid use disordermeetingsmemberminority communitiesnovelopioid mortalityopioid overdoseopioid use disorderoverdose deathoverdose educationoverdose preventionracial disparityracial minorityracial minority populationresponsesatisfactionsexshared decision makingsocial health determinantssocial stigmasociodemographicstreatment as usualtrend
项目摘要
Project Summary/Abstract
This supplement aims to explore the impact of the infusion of health equity principles on overdose prevention
strategies during implementation of the Communities That Heal (CTH) intervention as part of the HEALing
Communities Study (HCS). The HCS is a multi-site, parallel arm, cluster randomized, wait-list controlled trial
evaluating the impact of the CTH intervention compared with usual care in wait-list communities, on overdose
deaths. The overall goal of the HCS is to reduce opioid overdose deaths by 40% in 67 HCS communities
across four states. Communities form coalitions to make shared decisions about what overdose prevention
strategies to implement and how best to implement them, particularly strategies that promote Overdose
Prevention Education and Naloxone Distribution (OEND) and Medications for Opioid Use Disorder (MOUD).
While it is known that minoritized communities (whether due to race, ethnicity, gender, or LGBTQIA+ status)
have less and poorer access to treatment for Opioid Use Disorder (OUD) and associated disparities in
outcomes, at its outset, HCS did not explicitly aim to reduce disparities or measure the effect of centering
equity on overdose prevention. This approach changed in 2020 with acute awareness of the racial and ethnic
disparities within the COVID epidemic and the racial awakening in response to the George Floyd killing. This
supplement will leverage the existing infrastructure and study stuff of its parent study to analyze survey and
other qualitative data already collected. The primary data sources will include surveys of coalition members,
completed at four time points during the study period; the Opioid-Overdose Reduction Continuum of Care
Approach Tracker (ORCCAT), completed monthly by study staff, that includes overdose prevention information
by strategy, sector, venue, population served, coalition approval date, implementation plan developed, date
started, number of partners/practices associated with strategy, and mode of delivery; and REACH data,
completed by study staff monthly once each strategy is implemented that includes information on number of
persons reached and demographics of those reached (e.g., race, ethnicity, sex, age). Data analysis will include
both quantitative analysis looking at associations between survey answers regarding health equity topics and
incorporation of equity into strategies, as well as qualitative analysis examining how coalitions discussed and
prioritized equity topics. This study will be guided by the parent study’s PRISM/RE-AIM(S) conceptual
framework with a novel health equity lens to examine how diversifying coalitions and infusing opioid overdose
prevention strategies with health equity principles may help reach minoritized communities and how these
contextual factors and processes may interact to promote or impede health equity. Results from this study may
be used to inform policies, strategies, and practices for incorporating health equity principles when
implementing overdose prevention strategies.
项目摘要/摘要
本附录旨在探讨健康公平原则的灌输对预防过量用药的影响
实施社区康复(Cth)干预作为康复的一部分的策略
社区研究(HCS)。HCS是一项多站点、平行臂、整群随机、等待名单对照试验
评估Cth干预与等待名单社区常规护理对过量用药的影响
死亡。HCS的总体目标是将67个HCS社区的阿片类药物过量死亡人数减少40%
横跨四个州。社区组成联盟,就预防服药过量做出共同决定
实施战略以及如何最好地实施这些战略,特别是促进吸毒过量的战略
预防教育和纳洛酮分配(OEND)和阿片类药物使用障碍(MOUD)。
虽然众所周知,小型化的社区(无论是由于种族、族裔、性别或LGBTQIA+地位)
获得阿片类药物使用障碍(OUD)治疗的机会越来越少,
结果,初级保健服务从一开始就没有明确的目标是缩小差距或衡量集中的影响
预防服药过量的公平。随着对种族和民族的敏锐认识,这种方法在2020年发生了变化
COVID疫情和乔治·弗洛伊德被杀事件引发的种族觉醒之间的差异。这
附录将利用其母研究的现有基础设施和研究人员来分析调查和
其他已收集的定性数据。主要数据来源将包括对联盟成员的调查,
在研究期间的四个时间点完成;阿片类药物过量减少连续护理
方法跟踪器(ORCCAT),由研究人员每月完成,其中包括过量服药预防信息
按战略、部门、地点、服务人口、联盟批准日期、制定的实施计划、日期
已启动、与战略相关的合作伙伴/实践的数量、交付模式;以及可获得的数据;
由研究人员在每个策略实施后每月完成,其中包括以下信息
被联系的人和被联系的人的人口统计(例如,种族、民族、性别、年龄)。数据分析将包括
这两种定量分析都着眼于关于健康公平主题的调查答案与
将股权纳入战略,以及对联盟如何讨论和
确定股权主题的优先顺序。本研究将以家长研究的PRISM/RE-AIM(S)概念为指导
框架和一个新的健康公平透镜,以检查多样化的联合和注入阿片类药物过量
具有健康公平原则的预防战略可能有助于到达小规模社区,以及这些战略如何
背景因素和进程可能相互作用,以促进或阻碍健康公平。这项研究的结果可能
用于在以下情况下为纳入健康公平原则的政策、战略和实践提供信息
实施过量用药预防策略。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Applied risk mapping and spatial analysis of address-level decedent data to inform opioid overdose interventions: The Massachusetts HEALing Communities Study.
应用地址级死者数据的风险绘图和空间分析来为阿片类药物过量干预提供信息:马萨诸塞州治愈社区研究。
- DOI:10.1016/j.drugalcdep.2023.110947
- 发表时间:2023
- 期刊:
- 影响因子:4.2
- 作者:Pustz,Jennifer;Srinivasan,Sumeeta;Shrestha,Shikhar;Larochelle,MarcR;Walley,AlexanderY;Samet,JeffreyH;Babakhanlou-Chase,Hermik;Carpenter,JaneF;Stopka,ThomasJ
- 通讯作者:Stopka,ThomasJ
Intranasal Naloxone for Opioid Overdose.
鼻内纳洛酮治疗阿片类药物过量。
- DOI:10.1001/jama.2023.23248
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Taylor,JessicaL;Lasser,KarenE
- 通讯作者:Lasser,KarenE
Mobile treatment for opioid use disorder: Implementation of community-based, same-day medication access interventions.
阿片类药物使用障碍的移动治疗:实施基于社区的当天药物获取干预措施。
- DOI:10.1016/j.josat.2023.209272
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Chatterjee,Avik;Baker,Trevor;Rudorf,Maria;Walt,Galya;Stotz,Caroline;Martin,Anna;Kinnard,ElizabethN;McAlearney,AnnScheck;Bosak,Julie;Medley,Bethany;Pinkhover,Allyson;Taylor,JessicaL;Samet,JeffreyH;Lunze,Karsten
- 通讯作者:Lunze,Karsten
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY H. SAMET其他文献
JEFFREY H. SAMET的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY H. SAMET', 18)}}的其他基金
The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center
国际城市酒精艾滋病毒/艾滋病研究合作中心 (ARCH)
- 批准号:
10845873 - 财政年份:2021
- 资助金额:
$ 79.98万 - 项目类别:
The International Uganda Russia Boston Alcohol Network for Alcohol Research Collaboration on HIV/AIDS (URBAN ARCH) Center
国际乌干达俄罗斯波士顿酒精网络艾滋病毒/艾滋病酒精研究合作 (URBAN ARCH) 中心
- 批准号:
10303983 - 财政年份:2021
- 资助金额:
$ 79.98万 - 项目类别:
The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center
国际城市酒精艾滋病毒/艾滋病研究合作中心 (ARCH)
- 批准号:
10683765 - 财政年份:2021
- 资助金额:
$ 79.98万 - 项目类别:
MassHEAL - Reducing overdose deaths by 40% (2019-2023)
MassHEAL%20-%20减少%20过量%20死亡%20by%2040%%20(2019-2023)
- 批准号:
10609256 - 财政年份:2019
- 资助金额:
$ 79.98万 - 项目类别:
MassHEAL - Reducing overdose deaths by 40% (2019-2023)
MassHEAL%20-%20减少%20过量%20死亡%20by%2040%%20(2019-2023)
- 批准号:
9917749 - 财政年份:2019
- 资助金额:
$ 79.98万 - 项目类别:
Pilot Study of Opioid-receptor Antagonists to Reduce Pain and Inflammation among HIV-Infected Persons with Alcohol Problems
阿片受体拮抗剂减轻有酗酒问题的艾滋病毒感染者疼痛和炎症的初步研究
- 批准号:
9985430 - 财政年份:2019
- 资助金额:
$ 79.98万 - 项目类别:
MassHEAL - Reducing overdose deaths by 40% (2019-2023)
MassHEAL%20-%20减少%20过量%20死亡%20by%2040%%20(2019-2023)
- 批准号:
10351640 - 财政年份:2019
- 资助金额:
$ 79.98万 - 项目类别:
Pilot Study of Opioid-receptor Antagonists to Reduce Pain and Inflammation among HIV-Infected Persons with Alcohol Problems
阿片受体拮抗剂减轻有酗酒问题的艾滋病毒感染者疼痛和炎症的初步研究
- 批准号:
10019309 - 财政年份:2019
- 资助金额:
$ 79.98万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 79.98万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 79.98万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 79.98万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 79.98万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 79.98万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 79.98万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 79.98万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 79.98万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 79.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 79.98万 - 项目类别:
Operating Grants